The FDA named Dexcom its first TEMPO participant, allowing digital health devices to reach Medicare patients before authorisation in exchange for real-world data.
It is intended to let patients and their clinicians monitor metabolic and nutritional status, receive tailored guidance, and access real-time data and AI insights for behavioural changes.
It’s for “Digital Health Devices.”
Maaaaan. If only I were rich and living in the US. It’s a new frontier of snake oil.
Just get in His Majesty’s good graces and go to town.
It’s a glucose monitor, like diabetics already use, it’s not snake oil.